Franklin Genomic Advancements ETF (HELX)
BATS: HELX · Real-Time Price · USD
28.36
+0.42 (1.51%)
At close: Jul 9, 2025, 4:00 PM
28.36
0.00 (0.00%)
After-hours: Jul 9, 2025, 8:00 PM EDT
HELX Holdings Information
HELX is an equity ETF with a total of 67 individual holdings. The top holdings are Natera stock at 6.30%, Vertex Pharmaceuticals at 4.30%, Samsung Biologics at 4.21%, Guardant Health at 3.83%, and Alnylam Pharmaceuticals at 3.76%.
Total Holdings
67
Top 10 Percentage
38.94%
Asset Class
Equity
ETF Category
Health
Assets
11.25M
PE Ratio
26.71
Sector Allocation
Top 25 Holdings
As of Jul 8, 2025
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NTRA | Natera, Inc. | 6.30% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 4.30% |
| 3 | KRX: 207940 | Samsung Biologics Co.,Ltd. | 4.21% |
| 4 | GH | Guardant Health, Inc. | 3.83% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.76% |
| 6 | KRYS | Krystal Biotech, Inc. | 3.44% |
| 7 | CTVA | Corteva, Inc. | 3.42% |
| 8 | MEDP | Medpace Holdings, Inc. | 3.29% |
| 9 | LLY | Eli Lilly and Company | 3.21% |
| 10 | INSM | Insmed Incorporated | 3.20% |
| 11 | UTHR | United Therapeutics Corporation | 2.91% |
| 12 | AZN | AstraZeneca PLC | 2.78% |
| 13 | BNTX | BioNTech SE | 2.66% |
| 14 | n/a | Us Dollar | 2.61% |
| 15 | BBIO | BridgeBio Pharma, Inc. | 2.56% |
| 16 | ETR: SRT3 | Sartorius Aktiengesellschaft | 2.45% |
| 17 | CDNS | Cadence Design Systems, Inc. | 2.38% |
| 18 | REGN | Regeneron Pharmaceuticals, Inc. | 2.29% |
| 19 | RARE | Ultragenyx Pharmaceutical Inc. | 2.08% |
| 20 | DHR | Danaher Corporation | 1.90% |
| 21 | EXAS | Exact Sciences Corporation | 1.82% |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 1.80% |
| 23 | TMO | Thermo Fisher Scientific Inc. | 1.77% |
| 24 | QGEN | Qiagen N.V. | 1.76% |
| 25 | TWST | Twist Bioscience Corporation | 1.66% |
As of Jul 8, 2025